Is it Helpful to Take Cannabis Before Exposure Therapy for Panic Disorder?

PostedMarch 3, 2026

UpdatedMarch 3, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Some patients explore cannabis before exposure therapy for panic disorder to manage anxiety during challenging therapy sessions. Using cannabis as a pre-session cannabis aid may support comfort and engagement in exposure-based treatments.

Potential Role in Therapy

Understanding cannabis before exposure therapy for panic can help guide its safe integration as an adjunctive tool in treatment.

ERP Adjunct

Cannabis may serve as an ERP adjunct, potentially easing anxiety and allowing patients to engage more fully in exposure exercises.

Therapy Preparation

Using pre-session cannabis could assist in therapy preparation, helping reduce anticipatory anxiety before confronting panic triggers.

Symptom Moderation

Careful application of cannabis before exposure therapy for panic may moderate panic symptoms, enabling more effective participation in sessions without excessive sedation or impairment.

Clinical Considerations

While cannabis before exposure therapy for panic might offer benefits, clinicians must consider dosage, timing, and individual response to avoid interfering with therapy outcomes.

Taking cannabis as a pre-session cannabis strategy or ERP adjunct may help patients manage anxiety during exposure therapy. Professional guidance ensures that cannabis before exposure therapy for panic is used safely and enhances, rather than hinders, therapy effectiveness.

If you’re exploring cannabis treatment options for panic disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Panic Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.